
Raymond J. Henley Iii
Examiner (ID: 7179, Phone: (571)272-0575 , Office: P/1629 )
| Most Active Art Unit | 1614 |
| Art Unit(s) | 1205, 2899, 1629, 1614, 1621 |
| Total Applications | 4324 |
| Issued Applications | 3034 |
| Pending Applications | 603 |
| Abandoned Applications | 710 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10267047
[patent_doc_number] => 20150152044
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-04
[patent_title] => 'DESFESOTERODINE SALTS'
[patent_app_type] => utility
[patent_app_number] => 14/406649
[patent_app_country] => US
[patent_app_date] => 2013-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7748
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14406649
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/406649 | Desfesoterodine salts | Jun 13, 2013 | Issued |
Array
(
[id] => 10968178
[patent_doc_number] => 20140371211
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-18
[patent_title] => 'Piroxicam Transdermal Composition to Treat Plantar Fasciitis'
[patent_app_type] => utility
[patent_app_number] => 13/917304
[patent_app_country] => US
[patent_app_date] => 2013-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6160
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13917304
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/917304 | Piroxicam transdermal composition to treat plantar fasciitis | Jun 12, 2013 | Issued |
Array
(
[id] => 10288356
[patent_doc_number] => 20150173354
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-25
[patent_title] => 'Aqueous Composition Comprising Dicamba and a Drift Control Agent'
[patent_app_type] => utility
[patent_app_number] => 14/408172
[patent_app_country] => US
[patent_app_date] => 2013-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8444
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14408172
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/408172 | Aqueous composition comprising dicamba and a drift control agent | Jun 10, 2013 | Issued |
Array
(
[id] => 9491773
[patent_doc_number] => 20140142179
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-22
[patent_title] => '4-HYDROXYBUTYRIC ACID ANALOGS'
[patent_app_type] => utility
[patent_app_number] => 13/914127
[patent_app_country] => US
[patent_app_date] => 2013-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9308
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13914127
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/914127 | 4-hydroxybutyric acid analogs | Jun 9, 2013 | Issued |
Array
(
[id] => 11799593
[patent_doc_number] => 09540382
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-10
[patent_title] => 'Crystalline forms of a Bruton\'s tyrosine kinase inhibitor'
[patent_app_type] => utility
[patent_app_number] => 14/405317
[patent_app_country] => US
[patent_app_date] => 2013-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 41500
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 160
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14405317
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/405317 | Crystalline forms of a Bruton's tyrosine kinase inhibitor | Jun 2, 2013 | Issued |
Array
(
[id] => 9263351
[patent_doc_number] => 20130345280
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-26
[patent_title] => 'Methods And Compositions Employing Bicifadine For Treating Disability Or Functional Impairment Associated With Acute Pain, Chronic Pain, Or Neuropathic Disorders'
[patent_app_type] => utility
[patent_app_number] => 13/907920
[patent_app_country] => US
[patent_app_date] => 2013-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 28949
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13907920
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/907920 | Methods and compositions employing bicifadine for treating disability or functional impairment associated with acute pain, chronic pain, or neuropathic disorders | Jun 1, 2013 | Issued |
Array
(
[id] => 10044395
[patent_doc_number] => 09084778
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-21
[patent_title] => 'Topical compositions containing a retinoid of the oil-in-water emulsion type'
[patent_app_type] => utility
[patent_app_number] => 13/906336
[patent_app_country] => US
[patent_app_date] => 2013-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10174
[patent_no_of_claims] => 73
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13906336
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/906336 | Topical compositions containing a retinoid of the oil-in-water emulsion type | May 29, 2013 | Issued |
Array
(
[id] => 9094966
[patent_doc_number] => 20130274277
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-17
[patent_title] => 'TREATMENT FOR DISCOID LUPUS'
[patent_app_type] => utility
[patent_app_number] => 13/906083
[patent_app_country] => US
[patent_app_date] => 2013-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 21629
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13906083
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/906083 | TREATMENT FOR DISCOID LUPUS | May 29, 2013 | Abandoned |
Array
(
[id] => 9922936
[patent_doc_number] => 08980898
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-17
[patent_title] => 'Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases'
[patent_app_type] => utility
[patent_app_number] => 13/904634
[patent_app_country] => US
[patent_app_date] => 2013-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 55348
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13904634
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/904634 | Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases | May 28, 2013 | Issued |
Array
(
[id] => 11798541
[patent_doc_number] => 09539259
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-10
[patent_title] => 'Compounds and methods of use thereof for treating neurodegenerative disorders'
[patent_app_type] => utility
[patent_app_number] => 14/403523
[patent_app_country] => US
[patent_app_date] => 2013-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 25
[patent_no_of_words] => 27820
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14403523
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/403523 | Compounds and methods of use thereof for treating neurodegenerative disorders | May 22, 2013 | Issued |
Array
(
[id] => 10515890
[patent_doc_number] => 09242928
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-01-26
[patent_title] => 'Compound, kinesin spindle protein inhibitor, and application thereof'
[patent_app_type] => utility
[patent_app_number] => 13/901282
[patent_app_country] => US
[patent_app_date] => 2013-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 12257
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13901282
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/901282 | Compound, kinesin spindle protein inhibitor, and application thereof | May 22, 2013 | Issued |
Array
(
[id] => 9069580
[patent_doc_number] => 20130261336
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-03
[patent_title] => 'METHODS AND COMPOSITIONS FOR INCREASING THE ANAEROBIC WORKING CAPACITY IN TISSUES'
[patent_app_type] => utility
[patent_app_number] => 13/900244
[patent_app_country] => US
[patent_app_date] => 2013-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 11784
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13900244
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/900244 | Methods and compositions for increasing the anaerobic working capacity in tissues | May 21, 2013 | Issued |
Array
(
[id] => 10888230
[patent_doc_number] => 08912226
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-12-16
[patent_title] => 'Pharmaceutical composition comprising (1r,4r) -6′-fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and a NSAR'
[patent_app_type] => utility
[patent_app_number] => 13/892732
[patent_app_country] => US
[patent_app_date] => 2013-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 15693
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13892732
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/892732 | Pharmaceutical composition comprising (1r,4r) -6′-fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and a NSAR | May 12, 2013 | Issued |
Array
(
[id] => 9175116
[patent_doc_number] => 20130317101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-28
[patent_title] => 'SINGLETON INHIBITORS OF SUMOYLATION ENZYMES AND METHODS FOR THEIR USE'
[patent_app_type] => utility
[patent_app_number] => 13/891067
[patent_app_country] => US
[patent_app_date] => 2013-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 18552
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13891067
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/891067 | Singleton inhibitors of sumoylation enzymes and methods for their use | May 8, 2013 | Issued |
Array
(
[id] => 9175058
[patent_doc_number] => 20130317043
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-28
[patent_title] => 'Compounds and Methods for Treating Autoimmune Diseases'
[patent_app_type] => utility
[patent_app_number] => 13/887466
[patent_app_country] => US
[patent_app_date] => 2013-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 17573
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13887466
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/887466 | Compounds and methods for treating autoimmune diseases | May 5, 2013 | Issued |
Array
(
[id] => 12036481
[patent_doc_number] => 09814693
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-14
[patent_title] => 'Veterinary use of dianhydrogalactitol, diacetyldianhydrogalactitol, and dibromodulcitol to treat malignancies'
[patent_app_type] => utility
[patent_app_number] => 14/400271
[patent_app_country] => US
[patent_app_date] => 2013-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 13
[patent_no_of_words] => 32601
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14400271
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/400271 | Veterinary use of dianhydrogalactitol, diacetyldianhydrogalactitol, and dibromodulcitol to treat malignancies | May 2, 2013 | Issued |
Array
(
[id] => 11783952
[patent_doc_number] => 09393225
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-07-19
[patent_title] => 'Melanoma chemoprevention'
[patent_app_type] => utility
[patent_app_number] => 14/398713
[patent_app_country] => US
[patent_app_date] => 2013-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 27
[patent_no_of_words] => 15554
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14398713
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/398713 | Melanoma chemoprevention | May 2, 2013 | Issued |
Array
(
[id] => 10248497
[patent_doc_number] => 20150133494
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-14
[patent_title] => 'Method of Treating Cancer'
[patent_app_type] => utility
[patent_app_number] => 14/398188
[patent_app_country] => US
[patent_app_date] => 2013-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12258
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14398188
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/398188 | Method of treating cancer | May 1, 2013 | Issued |
Array
(
[id] => 9677001
[patent_doc_number] => 08815911
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-08-26
[patent_title] => 'Alfentanil composition for the treatment of acute pain'
[patent_app_type] => utility
[patent_app_number] => 13/874762
[patent_app_country] => US
[patent_app_date] => 2013-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12590
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13874762
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/874762 | Alfentanil composition for the treatment of acute pain | Apr 30, 2013 | Issued |
Array
(
[id] => 10241499
[patent_doc_number] => 20150126494
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-07
[patent_title] => 'NON-RETINOID ANTAGONISTS FOR TREATMENT OF AGE-RELATED MACULAR DEGENERATION AND STARGARDT DISEASE'
[patent_app_type] => utility
[patent_app_number] => 14/398342
[patent_app_country] => US
[patent_app_date] => 2013-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 9967
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14398342
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/398342 | Non-retinoid antagonists for treatment of age-related macular degeneration and stargardt disease | Apr 29, 2013 | Issued |